Skip to main content

Table 2 Prognostic factors for cancer-specific survival in 147 patients with esophageal cancer

From: Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy

Variables

Patients (n = 147)

Category or characteristics

Univariate

Multivariate

HR

95 % CI

p value

HR

95 % CI

p value

Gender

15/132

(female/male)

0.942

0.406–2.740

0.9007

   

Age

46/101

(70</≥70)

1.427

0.742–2.639

0.2771

   

pStage

92/55

(1,2/3)

4.876

2.625–9.420

<0.0001

4.19

2.146–8.562

<0.0001

Tumor size

45/102

(3</≥3)

3.405

1.548–8.981

0.0014

1.433

0.580–4.056

0.4493

Operation time

99/48

(600</≥600)

2.041

1.116–3.741

0.0209

1.425

0.757–2.681

0.2699

Intraoperative blood loss

72/75

(500</≥500)

1.321

0.723–2.463

0.3663

   

LMR

83/64

(≥4.0/4.0<)

2.829

1.537–5.378

0.0008

2.372

1.198–4.840

0.0129

NLR

37/110

(≥1.6/1.6<)

1.469

0.753–2.734

0.2494

   

PLR

79/68

(147</≥147)

2.013

1.100–3.783

0.0232

1.12

0.611–2.404

0.5999

SCC antigen

109/38

(1.5</≥1.5)

1.3

0.603–2.564

0.4842

   
  1. LMR lymphocyte to monocyte ratio, NLR neutrophil to lymphocyte ratio, PLR platelet lymphocyte ratio, SCC squamous cell carcinoma, HR hazard ratio, CI confidence interval